Skip to main content
Premium Trial:

Request an Annual Quote

NIH: "Call Me!"

After Writedit at Medical Writing, Editing and Grantsmanship criticized the National Center for Research Resources Task Force's "straw model" of proposed re-locations for NCRR projects and the National Institutes of Health's request for users' comments, the agency this week announced conference calls in which stakeholder communities can voice their opinions on the matter. NIH invites users to "join any of the discussions that may be relevant to you to share your comments and ask questions," according to its Feedback site. Complete call schedule and dial-in information is available here.

HT: Jeremy Berg at the NIGMS Feedback Loop

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.